Asthma in older adults with severe coronavirus disease 2019: Clinical outcomes and predictors of mortality.
作者信息
Avdeev Sergey N, Pozdnakova Anna A, Gaynitdinova Viliya V, Chikina Svetlana Yu, Vlasenko Anna E
机构信息
Department of Pulmonology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Emergency Department, University Clinical Hospital No.4, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
出版信息
Ann Allergy Asthma Immunol. 2022 Feb;128(2):213-215. doi: 10.1016/j.anai.2021.10.016. Epub 2021 Oct 17.
Abstract
摘要
相似文献
1
Asthma in older adults with severe coronavirus disease 2019: Clinical outcomes and predictors of mortality.患有严重2019冠状病毒病的老年人的哮喘：临床结局和死亡率预测因素。
Ann Allergy Asthma Immunol. 2022 Feb;128(2):213-215. doi: 10.1016/j.anai.2021.10.016. Epub 2021 Oct 17.
2
Predictors for in-hospital mortality from coronavirus disease 2019 (COVID-19) infection among adults aged 18-65 years.18至65岁成年人中2019冠状病毒病（COVID-19）感染的院内死亡预测因素。
Infect Control Hosp Epidemiol. 2021 Jun;42(6):772-775. doi: 10.1017/ice.2020.1390. Epub 2020 Dec 16.
3
Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry.成人重度哮喘对新型冠状病毒肺炎疾病的预后无显著影响：来自意大利重度哮喘登记处的结果
Allergy. 2021 Mar;76(3):902-905. doi: 10.1111/all.14558. Epub 2020 Sep 16.
4
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19.老年 COVID-19 住院患者院内死亡的临床特征和预测因素。
Age Ageing. 2021 Feb 26;50(2):326-334. doi: 10.1093/ageing/afaa258.
5
Are women with asthma at increased risk for severe COVID-19?哮喘女性患重症 COVID-19 的风险会增加吗？
Lancet Respir Med. 2021 Feb;9(2):125-126. doi: 10.1016/S2213-2600(21)00007-2. Epub 2021 Jan 12.
6
Clinical course and outcomes of patients with asthma hospitalized for severe acute respiratory syndrome coronavirus 2 pneumonia: A single-center, retrospective study.因严重急性呼吸综合征冠状病毒2型肺炎住院的哮喘患者的临床病程及结局：一项单中心回顾性研究。
Ann Allergy Asthma Immunol. 2020 Dec;125(6):707-709. doi: 10.1016/j.anai.2020.07.029. Epub 2020 Aug 1.
7
The impact of COVID-19 on patients with asthma.COVID-19 对哮喘患者的影响。
Eur Respir J. 2021 Mar 4;57(3). doi: 10.1183/13993003.03142-2020. Print 2021 Mar.
8
Asthma and COVID-19: Emphasis on Adequate Asthma Control.哮喘与 COVID-19：重视哮喘的充分控制。
Can Respir J. 2021 Aug 24;2021:9621572. doi: 10.1155/2021/9621572. eCollection 2021.
9
Evaluation of the impact of shielding to avoid COVID-19 infection on respiratory symptoms in children with severe asthma.评估为避免新型冠状病毒肺炎感染而采取的防护措施对重度哮喘儿童呼吸道症状的影响。
Arch Dis Child. 2021 Apr;106(4):e23. doi: 10.1136/archdischild-2020-320498. Epub 2020 Oct 27.
10
Biological therapies, asthma and coronavirus disease 2019.生物疗法、哮喘与 2019 年冠状病毒病。
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):597-601. doi: 10.1097/ACI.0000000000000783.
引用本文的文献
1
The polyhedric reality of the interaction between COVID-19, asthma and inhaled corticosteroids.新型冠状病毒肺炎、哮喘与吸入性糖皮质激素之间相互作用的多面现实
ERJ Open Res. 2022 May 30;8(2). doi: 10.1183/23120541.00179-2022. eCollection 2022 Apr.
本文引用的文献
1
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence.COVID-19 风险和结局在接受生物制剂或全身皮质类固醇治疗的成年哮喘患者中的：全国真实世界证据。
J Allergy Clin Immunol. 2021 Aug;148(2):361-367.e13. doi: 10.1016/j.jaci.2021.06.006. Epub 2021 Jun 15.
2
Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.新型冠状病毒肺炎患者中哮喘表型、相关共病和长期症状。
Allergy. 2022 Jan;77(1):173-185. doi: 10.1111/all.14972. Epub 2021 Jun 19.
3
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.哮喘患者的嗜酸性粒细胞增多对严重的COVID-19疾病具有保护作用。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1152-1162.e3. doi: 10.1016/j.jaip.2020.12.045. Epub 2021 Jan 23.
4
Asthma in elderly is characterized by increased sputum neutrophils, lower airway caliber variability and air trapping.老年哮喘的特征是痰中性粒细胞增多、下气道口径变化和空气滞留。
Respir Res. 2021 Jan 13;22(1):15. doi: 10.1186/s12931-021-01619-w.
5
Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019.哮喘与2019冠状病毒病患者插管风险增加相关，但与住院或死亡风险无关。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):93-95. doi: 10.1016/j.anai.2020.10.002. Epub 2020 Oct 12.
6
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments.意大利重症哮喘网络（SANI）患者中的新型冠状病毒肺炎：临床特征、合并症的影响及治疗情况
Allergy. 2021 Mar;76(3):887-892. doi: 10.1111/all.14532. Epub 2020 Aug 20.
7
Low prevalence of bronchial asthma and chronic obstructive lung disease among intensive care unit patients with COVID-19.新型冠状病毒肺炎重症监护病房患者中支气管哮喘和慢性阻塞性肺疾病的低患病率
Allergy. 2020 Oct;75(10):2703-2704. doi: 10.1111/all.14420. Epub 2020 Jun 12.
8
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局：一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
9
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.呼吸道过敏、哮喘与新型冠状病毒受体血管紧张素转换酶2表达的关联。
J Allergy Clin Immunol. 2020 Jul;146(1):203-206.e3. doi: 10.1016/j.jaci.2020.04.009. Epub 2020 Apr 22.
Zotero 插件